NCT04753034View on ClinicalTrials.gov

Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

May 3, 2021

Study Completion Date

May 3, 2021

Conditions

Atopic Dermatitis

Interventions

DRUG

TER-101

Active Comparator

DRUG

Vehicle

Placebo Comparator

Trial Locations (12)

27262

Teres Bio Site 08, High Point

28405

Teres Bio Site 11, Wilmington

33162

Teres Bio Site 12, North Miami Beach

33613

Teres Bio Site 10, Tampa

40241

Teres Bio Site 01, Louisville

47129

Teres Bio Site 02, Clarksville

64506

Teres Bio site 09, Saint Joseph

77845

Teres Bio Site 03, College Station

78229

Teres Bio Site 07, San Antonio

78660

Teres Bio Site 06, Pflugerville

85255

Teres Bio site 05, Scottsdale

92024

Teres Bio Site 04, Encinitas

All Listed Sponsors

lead

Teres Bio, Inc.

INDUSTRY

NCT04753034 - Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter